NCT01343342View on ClinicalTrials.gov

Genes, Omega-3 Fatty Acids and Cardiovascular Disease Risk Factors

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

March 31, 2026

Conditions
Cardiovascular Disease
Interventions
DIETARY_SUPPLEMENT

n-3 PUFA supplementation

3g per day of n-3 PUFA supplementation (1.9g EPA, 1.1g DHA). 5 capsules per day (1g fish oil each, 5g of fish oil/day)

Trial Locations (1)

G1V0A6

Institute of Nutraceutical and Functional Foods (INAF), Laval University, Québec

All Listed Sponsors
lead

Laval University

OTHER

NCT01343342 - Genes, Omega-3 Fatty Acids and Cardiovascular Disease Risk Factors | Biotech Hunter | Biotech Hunter